Epstein-Barr Virus (EBV) Reactivation, Its Treatment with Rituximab and Their Impact on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation for Hematological MalignanciesMauricette Michallet, Franck‐Emmanuel Nicolini, Fiorenza Barraco et al.|Blood|2016Cited by 4
Impact of Single or Associated CMV, EBV and BK Virus Reactivation Early after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse IncidenceMauricette Michallet, Anne‐Sophie Michallet, Mohamad Sobh et al.|Blood|2014Cited by 0